These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 29945344)

  • 1. Downregulation of MiR-431 expression associated with lymph node metastasis and promotes cell invasion in papillary thyroid carcinoma.
    Liu Y; Li L; Liu Z; Yuan Q; Lu X
    Cancer Biomark; 2018; 22(4):727-732. PubMed ID: 29945344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
    Zhang M; Wu W; Gao M; Fei Z
    Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL; Zhang H; Chen YL; Peng L
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
    [No Abstract]   [Full Text] [Related]  

  • 4. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2.
    Xue KC; Hu DD; Zhao L; Li N; Shen HY
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
    Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
    Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.
    Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
    Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
    Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor.
    Feng K; Liu Y; Xu LJ; Zhao LF; Jia CW; Xu MY
    Biomed Pharmacother; 2018 Aug; 104():686-698. PubMed ID: 29803929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma.
    Qiu Z; Li H; Wang J; Sun C
    Oncol Rep; 2017 Nov; 38(5):2735-2740. PubMed ID: 29048684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma.
    Wang Z; Zhang H; Zhang P; Dong W; He L
    Tumour Biol; 2016 Jun; 37(6):7633-44. PubMed ID: 26687649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1.
    Han J; Zhang M; Nie C; Jia J; Wang F; Yu J; Bi W; Liu B; Sheng R; He G; Kong L; Zheng L; Pang R; Ding Z; Chen L; Guan Q; Pan S; Meng X; Xu J; Liu L; Zhang J
    Cell Death Dis; 2019 Feb; 10(3):195. PubMed ID: 30814512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway.
    Zhou T; Zhong M; Zhang S; Wang Z; Xie R; Xiong C; Lv Y; Chen W; Yu J
    Cancer Biomark; 2018; 23(2):185-191. PubMed ID: 30175973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
    Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
    Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-202-3p functions as a tumor suppressor and reduces cell migration and invasion in papillary thyroid carcinoma.
    Chen J; Yin J; Liu J; Zhu RX; Zheng Y; Wang XL
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1145-1150. PubMed ID: 30779083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
    Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
    BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.
    Xia F; Chen Y; Jiang B; Du X; Peng Y; Wang W; Huang W; Feng T; Li X
    Cell Physiol Biochem; 2018; 50(5):1659-1672. PubMed ID: 30384358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-1301-3p suppresses tumor growth by downregulating PCNA in thyroid papillary cancer.
    Qiao DH; He XM; Yang H; Zhou Y; Deng X; Cheng L; Zhou XY
    Am J Otolaryngol; 2021; 42(2):102920. PubMed ID: 33454555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.
    Wei C; Song H; Sun X; Li D; Song J; Hua K; Fang L
    Oncol Rep; 2015 Jul; 34(1):211-20. PubMed ID: 26063221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of microRNA-155 in papillary thyroid carcinoma and its clinical significance].
    Zhu YZ; Zheng K; Zhang HH; Chen L; Wu KL; Ren CH; Wang ZC; Kong LJ; Ruan WH; Chen XJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Oct; 36(10):1364-1368. PubMed ID: 27777199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-199a-5p inhibits the progression of papillary thyroid carcinoma by targeting SNAI1.
    Ma S; Jia W; Ni S
    Biochem Biophys Res Commun; 2018 Feb; 497(1):181-186. PubMed ID: 29427661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.